Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method

被引：19

作者：

Callas, DD ^{[1
]}

Fareed, J ^{[1
]}

机构：

[1] LOYOLA UNIV,STRITCH SCH MED,DEPT PATHOL,MAYWOOD,IL 60153

来源：

THROMBOSIS RESEARCH | 1996年 / 83卷 / 06期

关键词：

thrombin inhibitors; efegatran sulfate; argatroban; hirudin; ecarin clotting time;

D O I：

10.1016/0049-3848(96)00155-7

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

页码：463 / 468

页数：6

共 16 条

[1]

Bagdy D., 1994, Acta Physiologica Hungarica, V82, P355

[2]

BAJUSZ S, 1978, INT J PEPT PROT RES, V12, P217

[3]

CALLAS DD, 1996, ANN HEMATOL, V1, pA58

[4]

KETTNER C, 1990, J BIOL CHEM, V265, P18289

[5]

SELECTIVE-INHIBITION OF THROMBIN BY (2R,4R)-4-METHYL-1-[N2-[(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINYL)SULFONYL]-L-ARGINYL)]-2-PIPERIDINECARBOXYLIC ACID [J].

KIKUMOTO, R ;

TAMAO, Y ;

TEZUKA, T ;

TONOMURA, S ;

HARA, H ;

NINOMIYA, K ;

HIJIKATA, A ;

OKAMOTO, S .

BIOCHEMISTRY, 1984, 23 (01) :85-90

[6]

DIRECT THROMBIN INHIBITORS IN CARDIOVASCULAR MEDICINE [J].

LEFKOVITS, J ;

TOPOL, EJ .

CIRCULATION, 1994, 90 (03) :1522-1536

[7]

NOWAK G, 1993, THROMB HAEMOSTASIS, V69, P1306

[8]

NOWAK G, 1996, ANN HEMATOL, V1, pA56

[9]

ANTITHROMBOTIC THERAPY IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY [J].

POPMA, JJ ;

COLLER, BS ;

OHMAN, EM ;

BITTL, JA ;

WEITZ, J ;

KUNTZ, RE ;

LEON, MB .

CHEST, 1995, 108 (04) :S486-S501

[10]

RADZIWON P, 1996, ANN HEMATOL, V1, pA57

← 1 2 →